Meeting Details - The meeting is scheduled for September 12, 2025, at 14:00 [1] - The location is at the conference room of Renfu Pharmaceutical Group in Wuhan [1] - Voting will be conducted both on-site and through the Shanghai Stock Exchange online voting system [1] Agenda - The meeting will start with the announcement of attendance and reading of the meeting guidelines [2] - Shareholders will review two main proposals: 1. Reappointment of Da Xin Accounting Firm as the auditor for the fiscal year 2025 [5] 2. Signing a financial services agreement with China Merchants Group Finance Co., Ltd. [10] Proposal 1: Reappointment of Da Xin Accounting Firm - The company proposes to reappoint Da Xin Accounting Firm for the 2025 financial year, with the audit fee not exceeding the 2024 fee of 5.2 million yuan [5][9] - Da Xin Accounting Firm has over 30 years of experience in securities services and has a network of 39 member firms globally [6] - The firm had a total revenue of 1.378 billion yuan in 2024, with 405 million yuan from securities services [6] Proposal 2: Financial Services Agreement with China Merchants Group Finance Co., Ltd. - The agreement aims to enhance the company's financing channels and reduce financing costs, with a maximum daily deposit balance of 200 million yuan and a maximum loan balance of 500 million yuan [10][11] - The agreement is classified as a related party transaction due to the ownership structure of China Merchants Group Finance Co., Ltd. [11] - The financial services agreement is set for a duration of three years [13]

Overview - Hason Trading (China) Co., Ltd. plans to jointly invest with related parties to establish a subsidiary named Zhongke Zhongcheng Supply Chain (Chengdu) Co., Ltd. with a registered capital of RMB 100 million, where Hason will contribute RMB 10 million for a 10% stake [1][2][3] Investment and Related Transactions - The investment involves Hason, Suzhou Chenling Optical Co., Ltd., and Zhongke Zhongcheng Robot Technology (Chengdu) Co., Ltd., with the latter two being controlled by Mr. Xia Yulong, who will hold over 5% of Hason's shares post-acquisition [2][3] - The total investment structure includes Chenling Optical contributing RMB 51 million (51%), Guangdong Zhigao contributing RMB 29 million (29%), Zhongke Zhongcheng contributing RMB 10 million (10%), and Hason contributing RMB 10 million (10%) [1][2][3] Approval and Compliance - The investment has been approved by Hason's board of directors and is exempt from shareholder meeting approval under Shanghai Stock Exchange regulations [3][11] - The independent directors have also recognized the transaction as compliant with legal regulations and fair to all shareholders [11] Company and Related Parties - Suzhou Chenling Optical Co., Ltd. was established in January 2022 with a registered capital of RMB 60 million, focusing on optical instruments and AI applications [4] - Zhongke Zhongcheng Robot Technology (Chengdu) Co., Ltd. was established in August 2025 with a registered capital of RMB 10 million, also focusing on robotics and AI [4][5] Future Operations - The new subsidiary will engage in various activities including industrial design, software development, and manufacturing of industrial robots, with the actual business scope subject to regulatory approval [8][10]

Group 1 - The independent directors of Hason Trading (China) Co., Ltd. held their third special meeting on September 2, 2025, via communication methods [1] - The meeting was convened and presided over by independent director Ms. Guo Chunran, with all independent directors present [1] - The independent directors reviewed and approved the proposal regarding the investment in a joint venture with related parties, concluding that the transaction complies with relevant laws and regulations, and is fair and reasonable [1] Group 2 - The independent directors unanimously agreed to submit the proposal for board review, with a voting result of 3 votes in favor, 0 votes against, and 0 abstentions [2]

Core Viewpoint - Zhejiang Hechuan Technology Co., Ltd. is transferring 13% equity of its subsidiary, Zhejiang Hechuan Humanoid Robot Co., Ltd., from minority shareholder Wang Zhibin to Ningbo Youlong Venture Capital Partnership for 1.5 million yuan, establishing a related party transaction [2][4][14]. Summary by Sections 1. Overview of Related Transactions - Wang Zhibin plans to transfer 13% equity (subscription amount of 6.5 million yuan, paid-in amount of 1.5 million yuan) of Hechuan Robot to Ningbo Youlong for 1.5 million yuan, with Ningbo Youlong assuming the corresponding paid-in capital obligations [2][4]. 2. Basic Information of Related Parties - Ningbo Youlong is associated with Wang Zhibin, who is the executive partner and holds 22.08% of its financial interests. Other partners include Yan Pengfei and Xiang Yandong, with Yan serving as a director and executive president of Hechuan Technology [5][8]. 3. Necessity and Impact of Related Transactions - The transaction is necessary for binding the core talent strategy of Hechuan Robot, facilitating employee equity incentives, and enhancing business stability. It will not adversely affect the company's operations or financial status [14][15]. 4. Approval Process for Related Transactions - The transaction was approved by the fifth board of directors and the supervisory board of Hechuan Technology, with independent directors expressing agreement. The transaction does not require shareholder meeting approval [3][15][16].

证券代码：603213 证券简称：镇洋发展 公告编号：2025-045 转债代码：113681 转债简称：镇洋转债 浙江沪杭甬高速公路股份有限公司（以下简称"浙江沪杭甬" ）、镇 浙江镇洋发展股份有限公司 第二届监事会第十六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 一、监事会会议召开情况 浙江镇洋发展股份有限公司（以下简称"公司"或"镇洋发展" ）第二届监事会第十六次会议于2025年9月2日在浙江省宁波市镇海 区宁波石化经济技术开发区海天中路655号712会议室以现场方式召开。 会议通知已于2025年8月27日以书面形式送达。本次会议应出席监事 议的召集、召开和表决程序均符合《公司法》《公司章程》及相关 法律法规的规定。 二、监事会会议审议情况 本次会议对以下议案进行逐项审议并表决，形成如下决议： （一）审议通过《关于本次交易符合上市公司重大资产重组相关 法律法规规定的议案》 洋发展经协商，拟由浙江沪杭甬向公司全体股东发行 A 股股份换股吸 收合并镇洋发展（以下简称"本次交易" ）。根据《上市公司重大资 ...

证券代码：603213 证券简称：镇洋发展 公告编号：2025-044 转债代码：113681 转债简称：镇洋转债 浙江镇洋发展股份有限公司 第二届董事会第二十七次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 一、董事会会议召开情况 浙江镇洋发展股份有限公司（以下简称"公司"或"镇洋发展" ）第二 届董事会第二十七次会议于 2025 年 9 月 2 日在浙江省宁波市镇海区宁波石 化经济技术开发区海天中路 655 号 712 会议室以现场结合通讯方式召开。 会议通知已于 2025 年 8 月 27 日以书面形式送达。本次会议应出席董事 9 名，实际出席董事 9 名。会议由董事长沈曙光先生主持，监事、高级管理 人员列席。本次会议的召集、召开和表决程序均符合《公司法》 《公司章程》 及相关法律法规的规定。 二、董事会会议审议情况 本次会议对以下议案进行逐项审议并表决，形成如下决议： （一）审议通过《关于本次交易符合上市公司重大资产重组相关法律 法规规定的议案》 浙江沪杭甬高速公路股份有限公司（以下简称"浙江沪杭甬" ...

Core Viewpoint - Zhejiang Hu-Hang-Yong Highway Co., Ltd. plans to absorb and merge with Zhejiang Zhenyang Development Co., Ltd. through a share exchange, with the aim of enhancing its business scope and operational efficiency [9][21]. Group 1: Transaction Overview - The transaction involves Zhejiang Hu-Hang-Yong issuing A-shares to exchange for all shares held by Zhenyang Development, leading to Zhenyang's delisting and eventual dissolution [9][21]. - The exchange ratio is set at 1:1.0800, meaning each share of Zhenyang will convert into 1.0800 shares of Zhejiang Hu-Hang-Yong [11][12]. - The A-share issuance price for Zhejiang Hu-Hang-Yong is determined at RMB 13.50 per share, with a premium of 29.83% over Zhenyang's average share price of RMB 11.23 [10][11]. Group 2: Financial Implications - Following the merger, Zhejiang Hu-Hang-Yong will inherit all assets, liabilities, and operations of Zhenyang, thereby expanding its business into the chemical sector [26][27]. - The total number of A-shares to be issued for the merger is approximately 477,246,833 shares, based on Zhenyang's total share capital of 441,895,215 shares [12][21]. - The merger is expected to optimize the governance structure and enhance resource allocation efficiency, thereby strengthening the company's competitive position [27]. Group 3: Shareholder Rights and Obligations - Shareholders of both companies who oppose the merger will have the right to request cash compensation for their shares, with the cash offer being provided by the controlling shareholder, Traffic Group [15][19]. - The merger will not change the actual controller of Zhejiang Hu-Hang-Yong, which remains Traffic Group, ensuring continuity in management and strategic direction [25][26]. - The cash dividend policy post-merger will ensure a minimum annual cash distribution of RMB 0.4100 per share for the next three years, subject to legal and regulatory compliance [25].

Overview of the Merger - The merger involves Zhejiang Huhangyong Expressway Co., Ltd. absorbing Zhejiang Zhanyang Development Co., Ltd. through a share exchange, with Zhejiang Huhangyong as the absorbing party and Zhejiang Zhanyang as the absorbed party [10][23] - After the merger, Zhejiang Zhanyang will terminate its listing and eventually deregister as a legal entity, while Zhejiang Huhangyong will inherit all assets, liabilities, and rights of Zhejiang Zhanyang [10][23] Share Exchange Details - The share exchange ratio is set at 1:1.0800, meaning each share of Zhejiang Zhanyang will be exchanged for 1.0800 shares of Zhejiang Huhangyong [12][13] - The issuance price for Zhejiang Huhangyong's A shares is set at RMB 13.50 per share, with a premium of 29.83% over the average price of Zhejiang Zhanyang's shares [11][12] Financial Implications - As of the signing of the proposal, Zhejiang Zhanyang has a total share capital of 441,895,215 shares, leading to the issuance of approximately 477,246,833 shares of Zhejiang Huhangyong for the merger [13] - The merger is classified as a major asset restructuring, with Zhejiang Huhangyong's total assets exceeding 50% of Zhejiang Zhanyang's total assets as of the end of 2024 [27] Regulatory and Compliance Aspects - The transaction is considered a related party transaction due to both companies being controlled by the same entity, the Transportation Group [27] - The merger does not constitute a restructuring listing, as there has been no change in control within the last 36 months [27] Cash Dividend Policy - Following the merger, Zhejiang Huhangyong plans to implement a cash dividend policy, ensuring a minimum annual cash distribution of RMB 0.4100 per share for the next three years, subject to legal and regulatory compliance [28] Business Impact - The merger is expected to enhance Zhejiang Huhangyong's operational capabilities, as it combines its expressway management expertise with Zhejiang Zhanyang's focus on chemical products, including chlor-alkali products and high-purity hydrogen [28]

证券代码：600165 证券简称：ST 宁科 公告编号：2025-096 宁夏中科生物科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次股东会的召集人是公司董事会，表决方式符合《中华人民共和国公司法》 及《公司章程》的规定，会议由董事长符杰先生主持。 议案名称：关于公司新增关联关系及 2025 年度日常关联交易预计的议案 审议结果：通过 表决情况： | | | 同意 | | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 股东类型 比例 | | | | 比例 | | | 比例 | | | | 票数 | | 票数 | | | 票数 | | | | | | （%） | | （%） | | | （%） | | | A股 | 218,998,690 | 99.4761 | 1,105,500 | 0.5021 | 47,800 | 0.0218 | | | (二) | 涉及重大事项，5%以下股东的 ...

证券日报网讯 9月2日晚间，禾川科技发布公告称，公司子公司浙江禾川人形机器人有限公司少数股东 王志斌先生持有禾川机器人40%的股权，现王志斌拟将持有的禾川机器人13%的股权作价150万元转让 给宁波游龙创业投资合伙企业（有限合伙），并由宁波游龙履行对应股权实缴出资义务。根据《上海证 券交易所科创板股票上市规则》等相关规定，基于实际重于形式原则，宁波游龙属于公司关联方，本次 股权转让形成公司与关联方共同投资的关联交易。上述股权转让完成后，禾川科技将与关联方宁波游龙 共同持有子公司禾川机器人的股权。 （文章来源：证券日报） ...